<DOC>
	<DOCNO>NCT01632657</DOCNO>
	<brief_summary>Patients unruptured brain aneurysm pain syndrome like trigeminal neuralgia often undergo minimally invasive brain surgery small incision , short duration procedure patient possibility go home day . Postoperative pain , nausea vomit sometimes difficult manage conventional medication . This affect recovery surgery often delay discharge hospital . This study look use medication call sumatriptan drug use treatment migraine headache long time . This drug work receptor line brain around nerve maybe associate pain . The purpose study determine pain medication sumatriptan give end surgery improve postoperative course term less pain , less nausea vomit generally well postoperative quality recovery . Our main hypothesis subcutaneous sumatriptan ( 6mg ) administer end surgery improve postoperative quality recovery 24 hour elective minimally invasive craniotomy .</brief_summary>
	<brief_title>Effect Sumatriptan Postoperative Quality Recovery After Elective Minimally Invasive Craniotomy</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Sumatriptan</mesh_term>
	<criteria>1 . Patients elective craniotomy clipping unruptured intracranial aneurysm 2 . Patients craniotomy microvascular decompression cranial nerve neuralgia 3 . Age 1880 4 . ASA I III 1 . Patients known history hypersensitivity Sumatriptan sulphonamides 2 . Patients known history Migraine 3 . Patients regular treatment Sumatriptan 4 . Patients history Ischemic heart disease Angina , Myocardial infarction . 5 . Patients rupture intracranial aneurysm . 6 . Patients history severe liver disease . 7 . Patients history stroke uncontrolled hypertension 8 . Inability give inform consent 9 . Pregnant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>